Laryngeal Precancerous Lesions: From Screening to Therapeutic Intervention
Authors:
- Daniela CernevDCDaniela Cernev
- Ana-Maria BuduABAna-Maria Budu
- Mariana ZapuhlihMZMariana Zapuhlih
- Elena TudorETElena Tudor
- Vasile CabacVCVasile Cabac
- 1 November 2025
- journal article
- Published by Editorial Office "Bulletin of the Academy of Sciences of Moldova. Medical Sciences"
- No. 3(83),p. 304-313
Abstract
Precancerous lesions of the larynx, including leukoplakia, erythroplakia, epithelial dysplasia, and recurrent papillomatosis, carry a variable risk of progression to squamous cell carcinoma and represent a critical point in laryngeal cancer prevention. The aim of this article is to synthesize current data on etiopathogenesis, screening, early diagnosis, and treatment options. The methodology consisted of a narrative review of the recent literature and international guidelines. The results show that the risk of malignant transformation depends on the degree of dysplasia (3-10% in mild cases, up to 35-40% in severe dysplasia). Modern endoscopic technologies, such as narrow band imaging and autofluorescence, improve diagnostic accuracy, while endoscopic excision with CO₂ or KTP laser remains the therapeutic standard. Emerging therapies - including photodynamic therapy, antivirals, antiangiogenic agents, and HPV vaccination - offer promising perspectives in reducing recurrences. In conclusion, the management of precancerous laryngeal lesions must be multidisciplinary and personalized, while the integration of molecular biomarkers and modern technologies provides future directions with significant impact on patient prognosisKeywords
This publication has 32 references indexed in Scilit:
- Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Nasal Cavity, Paranasal Sinuses and Skull BaseHead and Neck Pathology, 2022
- The ever‐increasing importance of cancer as a leading cause of premature death worldwideCancer, 2021
- An updated review of the epidemiological factors associated with recurrent respiratory papillomatosisLaryngoscope Investigative Otolaryngology, 2021
- Current and future management of recurrent respiratory papillomatosisLaryngoscope Investigative Otolaryngology, 2018
- Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What is New in the 2017 WHO Blue Book for Tumours of the Hypopharynx, Larynx, Trachea and Parapharyngeal SpaceHead and Neck Pathology, 2017
- Value of narrow band imaging in the early diagnosis of laryngeal cancerHead & Neck, 2014
- Neuroendocrine neoplasms of the larynx: An overviewHead & Neck, 2009
- Treatment and follow‐up of oral dysplasia — A systematic review and meta‐analysisHead & Neck, 2009
- Human papillomavirus (HPV) in head and neck cancerJournal of Clinical Virology, 2005
- Initial Results From the National Registry for Juvenile-Onset Recurrent Respiratory PapillomatosisJAMA Otolaryngology–Head & Neck Surgery, 1999